메뉴 건너뛰기




Volumn 97, Issue 2, 2001, Pages 202-207

Gonadotropin-releasing hormone antagonist protocol: A novel method of ovarian stimulation in poor responders

Author keywords

GnRH agonist; GnRH antagonist; Intracytoplasmic sperm injection; Poor response

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; TRIPTORELIN;

EID: 0034954341     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00535-2     Document Type: Article
Times cited : (79)

References (38)
  • 1
    • 0004698232 scopus 로고    scopus 로고
    • Jones HW, McDowell J, Acosta A, et al. The importance of the follicular phase to success and failure in in vitro fertilisation. Fertil Steril 1983;40:317-21.
  • 2
    • 0004668574 scopus 로고    scopus 로고
    • Jenkins JM, Davies DW, Devonport H, et al. Comparison of 'poor' responders with 'good' responders using a standard buserelin/human menopausal gonadotropin regime for in vitro fertilization. Hum Reprod 1991;6:918-21.
  • 4
    • 0004638507 scopus 로고    scopus 로고
    • Serafini P, Stone B, Kerin J, et al. An alternate approach to controlled ovarian hyperstimulation in 'poor responders': pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 1988;49:90-5.
  • 9
    • 0004675798 scopus 로고    scopus 로고
    • Felberbaum RE, Reissmann T, Kópker W, et al. Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin-releasing hormone (GnRH) antagonist Cetrorelix at different dosages. J Asst Reprod Genet 1996;13:216-22.
  • 10
    • 0004638011 scopus 로고    scopus 로고
    • Olivennes F, Fancin R, Bouchard P, et al. The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer programme. Fertil Steril 1994;62:468-76.
  • 11
    • 0004670866 scopus 로고    scopus 로고
    • Olivennes F, Fanchin R, Bouchard P, et al. Scheduled administration of a gonadotropin-releasing hormone antagonist (Cetrorelix) on day 8 of in vitro fertilization cycles: a pilot study. Hum Reprod 1995;10:1382-86.
  • 12
    • 0004702669 scopus 로고    scopus 로고
    • Albano C, Smitz J, Camus M, et al. Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotropin and gonadotropin-releasing hormone antagonist (Cetrorelix). Hum Reprod 1996;11:2114-18.
  • 13
    • 0004638180 scopus 로고    scopus 로고
    • Albano C, Smitz J, Camus M, et al. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 1997;67:917-22.
  • 14
    • 0004704096 scopus 로고    scopus 로고
    • Felberbaum RE. Cetrorelix in controlled ovarian stimulation for ART: results of phase III, multiple dose treatment. In: Proceedings of the 5th International Symposium on GnRH Analogues in Cancer and Human Reproduction (Abstract 28). Gyn Endocrinol 1999;13(Suppl 1).
  • 17
    • 0004703520 scopus 로고    scopus 로고
    • Winslow KL, Toner JP, Bryski RG, et al. The gonadotropin-releasing hormone agonist stimulation test - a sensitive predictor of performance in the flare-up in vitro fertilisation cycle. Fertil Steril 1991;56:711-17.
  • 18
    • 0004665518 scopus 로고    scopus 로고
    • Roest J, van Heusden AM, Mous H, et al. The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. Fertil Steril 1996;66:969-73.
  • 19
    • 0004638663 scopus 로고    scopus 로고
    • Van Steirteghem AC, Nagy Z, Joris H, et al. High fertilization and implantation rate after intracytoplasmic sperm injection. Hum Reprod 1993;8:1061-66.
  • 20
    • 0004638012 scopus 로고    scopus 로고
    • Al-Hasani S, Kópker W, Baschat AA, et al. Mini swim-up: a new technique of sperm preparation for ICSI. J Assist Reprod Genet 1995;12:428-33.
  • 21
    • 0004668575 scopus 로고    scopus 로고
    • Veeck L. Preembryo grading. In: Brown CL, Vaughn VM, Lumpkin K, editors. Atlas of the human oocyte and early concepts. Baltimore (USA): Williams & Wilkins, 1991. p. 121-31.
  • 22
    • 0004638013 scopus 로고    scopus 로고
    • Steer CV, Mills CL, Tan SL, et al. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an IVF-ET programme. Hum Reprod 1992;7:117-19.
  • 23
    • 0004659069 scopus 로고    scopus 로고
    • Feldberg D, Farhi J, Ashkenazi J, et al. Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343-46.
  • 24
    • 0004637652 scopus 로고    scopus 로고
    • Barri PN, Martinez F, Coroleu B, et al. Managing nonresponders. In: Kempers RD, Cohen J, Haney AF, Younger JB, editors. Proceedings of the XVI World Congress on Fertility and Sterility. 1998 Oct; San Francisco. Amsterdam: Elsevier, p. 127-37.
  • 26
    • 0004707968 scopus 로고    scopus 로고
    • Dor J, Seidman DS, Amudai E, et al. Adjuvant GH therapy in poor responders to IVF: a prospective randomized placebo controlled double blind study. Hum Reprod 1995;10:40-3.
  • 29
    • 0004696681 scopus 로고    scopus 로고
    • Meldrum DR, Wisot A, Hamilton F, et al. Routine pituitary suppression with leuprolide before ovarian stimulation for, oocyte retrieval. Fertil Steril 1989;51:455-59.
  • 30
    • 0004638508 scopus 로고    scopus 로고
    • Fujii S, Sagara M, Kudo H, et al. A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril 1997;67:1166-68.
  • 31
    • 0004638325 scopus 로고    scopus 로고
    • Ben-Rafael Z, Menashe Y, Mimon R, et al. Limitations in the use of combined gonadotropin-releasing hormone analog and human menopausal gonadotropin for in vitro fertilisation. In: Mashiach S, Ben-Rafael Z, Laufer N, Schenker JG, editors. Advances in assisted reproductive technologies. New York (NY, USA): Plenum Press, 1990. p. 17-30.
  • 32
    • 0004638509 scopus 로고    scopus 로고
    • Van Hooff MHA, Alberda AT, Huisman GJ, et al. Doubling the human menopausal gonadotropin dose in the course of an in vitro fertilization treatment cycle in low responders: a randomized study. Hum Reprod 1993;8:369-73.
  • 34
    • 0004675799 scopus 로고    scopus 로고
    • Olivennes F, Fanchin R, Bouchard P, et al. Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist. Fertil Steril 1996;66:151-53.
  • 35
    • 0004698233 scopus 로고    scopus 로고
    • Felberbaum RE, Reissmann T, Kópker W, et al. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur J Obstet Gyn Reprod Biol 1995;61:151-55.
  • 36
    • 0004699843 scopus 로고    scopus 로고
    • Felberbaum RE, Diedrich K. Ovarian stimulation in ART: use of GnRH antagonists. In: Proceedings of the XVI World Congress on Fertility and Sterility, 1998 Oct 4-9; San Francisco. Fertility and reproductive medicine. Amsterdam: Elsevier, 1998. p. 113-25.
  • 37
    • 0004675031 scopus 로고    scopus 로고
    • Moreno C, Ruiz A, Simon C, et al. Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod 1998;13:2126-29.
  • 38
    • 0004707696 scopus 로고    scopus 로고
    • Ludwig M, Al-Hasani S, Kupker W, et al. A new indication for an intracytoplasmic sperm injection procedure outside the cases of severe male factor infertility. Eur J Obstet Gyn Reprod Biol 1997;75:207-10.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.